行情

CMRX

CMRX

Chimerix
NASDAQ

实时行情|Nasdaq Last Sale

2.010
-0.070
-3.37%
已收盘, 16:00 01/22 EST
开盘
2.080
昨收
2.080
最高
2.095
最低
1.990
成交量
22.97万
成交额
--
52周最高
4.400
52周最低
1.250
市值
1.23亿
市盈率(TTM)
-0.8938
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CMRX 新闻

  • 沪指重挫2.75% 国际油价跌至七周低点
  • 新浪财经.27分钟前
  • 调查显示仅四成美国人有1000美元应急储蓄
  • 新浪财经.4小时前
  • 大众因排放造假丑闻在加拿大被罚1.5亿美元
  • 新浪财经综合.6小时前
  • 日本东京圈新房价格涨至1990年以来新高
  • 新浪财经综合.6小时前

更多

所属板块

生物技术和医学研究
+0.13%
制药与医学研究
-0.23%

热门股票

名称
价格
涨跌幅

CMRX 简况

Chimerix, Inc. is a biotechnology company. The Company is focused on discovering, developing and commercializing medicines that address unmet medical needs. Its lead compound, brincidofovir, is in development as an oral and intravenous (IV) formulation for the prevention and treatment of deoxyribonucleic acid (DNA) viruses, including smallpox, adenoviruses (AdV), and the human herpesviruses. It is also advancing the development of CMX521 for the treatment and prevention of norovirus. In addition, the Company has an active discovery program focusing on viral targets for which limited or no therapies are available. Brincidofovir is an investigational oral nucleotide analog that has shown spectrum antiviral activity against all five families of double-stranded deoxyribonucleic acid (dsDNA) viruses that affect humans. Oral and IV formulations of brincidofovir are in development, both of which deliver the active antiviral directly to the site of viral replication.
展开

Webull提供Chimerix Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。